Faster Cannabinoid Bioavailability: A 2025 Nanoemulsion Study
This cannabinoid bioavailability review examines a 2025 crossover study testing a nanoemulsified THC/CBD powder against standard oil drops in healthy volunteers. The study found faster absorption and higher cannabinoid exposure with the powder…
Florida Bar Introduces Hemp and THC Crafted Cocktails with New Events
Cannabis beverages want a seat at the table as Florida bars introduce hemp and THC crafted cocktails. These beverages create new clinical dosing challenges and social use patterns. Understanding cannabis beverages is essential for clinicians monitoring…
DC Mayor Proposes Allowing Cannabis Drinks – Clinical Insights
Cannabis beverages pharmacokinetics differ from traditional edibles, affecting onset and dosing. This article highlights clinical safety considerations for cannabis drinks. Understanding these differences is key for effective patient counseling.
PharmDs Explain What Happens When You Mix CBD and Alcohol Together
Pharmacokinetic interactions CBD alcohol can affect how both substances are metabolized in the liver. Patients often combine CBD and alcohol without understanding potential risks. This article highlights clinical effects and safety considerations for…
Cannabis Pharmacokinetics Review: THC, CBD, Dosing
This paper is a broad evidence review of human pharmacokinetic studies on THC and CBD. It helps clarify how route, formulation, food, sex, drug interactions, and patient factors can meaningfully change absorption and exposure. Its main limitation is that…
Docs: Driver had THC in blood before striking pedestrian in Blackford County – Fox 59
Cannabis impairment assessment challenges complicate legal and clinical interpretations of THC blood levels. This case highlights the difficulty in correlating THC presence with actual impairment. Understanding these challenges is crucial for patient…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change.
This pilot study evaluates cbd anorexia nervosa safety in a randomized, placebo-controlled trial. It focuses on tolerability and pharmacokinetics in affected women. The findings provide preliminary safety data for future research.
Behavioural, Pharmacokinetic, and Genetic Evidence of CBD-Oxycodone Interaction in Mice
This study investigated cannabidiol oxycodone interaction and its effects on opioid analgesia and pharmacokinetics. Acute CBD administration increased oxycodone exposure and analgesic duration. Chronic use accelerated tolerance development specific to…
WCN26-5407 Pharmacokinetics of Cannabidiol in People with Kidney Failure
This article reviews pharmacokinetics cannabidiol kidney failure, highlighting important clinical considerations. Understanding CBD metabolism in kidney failure is critical for safe cannabis medicine use. Clinicians should monitor emerging evidence on…
23rd State Establishes New Performance Standard for THC Beverages with Cohort 2 Data
THC beverage performance standards represent a critical advancement in cannabis therapeutics. These standards help inform dosing guidance and onset predictability for patients using cannabis beverages. Understanding these metrics is essential for safe…